Company Liquidation LTD

Company profile

Atopix Therapeutics Limited

UK company 08247158, incorporated on 10 October 2012.

OC459 Anti-Inflammatory | Atopix Therapeutics Ltd - www.grenzlandapotheke.de

Atopix Therapeutics Limited is a UK company with status liquidation founded in 2012 based in London.

Company number

08247158

Incorporated

10 Oct 2012

Companies House status

Liquidation

Company identity

Founded / incorporated

10 October 2012

Company number 08247158

Verify at Companies House

Legal name

ATOPIX THERAPEUTICS LIMITED

Company type

LTD

Region

London

Registered address

Unknown

Insolvency history

Yes

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller

Company Liquidation LTD

Atopix Therapeutics Limited

CRN 08247158

Direct and ultimate controller

00159271

CRN 00159271

Company events

Reference milestones and recent Companies House filing stream events.

1 event

10 Oct

2012

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2013

Funded years

2013

Age at first award

0 years

Projects

2013 Collaborative R&D Lead participant

Clinical utility of a CRTH2 antagonist, OC000459, as an anti-Th2 therapy in atopic dermatitis

1 Apr 2013 to 30 Sep 2015

Awarded

£1,752,944

Total cost £2,962,554

This study will evaluate a novel anti-Th2 therapy as a controller treatment of moderate-to-severe atopic dermatitis with the primary objective to prevent occurrence of disease flares, the major healthcare burden. OC000459 is an orally administered drug that inhibits the receptor CRTH2 expressed by Th2 lymphocytes, eosinophils and basophils. CRTH2 mediates...

Product types

Collaborative R&D